Logo - springer
Slogan - springer

Springer Healthcare | Ophthalmology and Therapy (Editorial Board)

Ophthalmology and Therapy

Ophthalmology and Therapy

ISSN: 2193-8245 (print version)
ISSN: 2193-6528 (electronic version)

Journal no. 40123



Tariq Aslam, Manchester Royal Eye Hospital, Manchester, UK


Terrence O’Brien, University of Miami, Miami, FL, USA

Editorial Board

The Editorial board are responsible for assisting the in-house editorial team by providing final decisions on papers when peer review is conflicting, contributing their own research, suggesting review topics and generally supporting the journal in its development.

Iqbal Ike K. Ahmed, University of Toronto, Canada
Jorge L. Alió, Vissum Instituto Oftalmologico de Alicante, Alicante, Spain
Renato Ambrósio Jr, Federal University of São Paulo, Brazil
Sanjay Asrani, Duke University Medical Center, Durham, NC, USA
José Cunha-Vaz, University of Coimbra, Coimbra, Portugal
Zisis Gatzioufas, University Eye Hospital Basel USB, Basel, Switzerland
Pedram Hamrah, Tufts Medical Center, Tufts University School of Medicine, Boston, MA, USA
Alon Harris, Indiana University School of Medicine, Indianapolis, IN, USA
Glen J. Jaffe, Duke University Medical Center, Durham, NC, USA
Peter K. Kaiser, Cole Eye Institute, Cleveland, OH, USA
Anselm Kampik, Ludwig-Maximilians-Universität München, Munich, Germany
Michael Karampelas, West Hertfordshire Hospitals NHS Trust, UK
Shigeru Kinoshita, Kyoto Prefectural University of Medicine, Kyoto, Japan
Anastasios G.P. Konstas, Aristotle University of Thessaloniki, Greece
Nikolaos Kozei, Ophthalmica Institute of Ophthalmology & Microsurgery, Thessaloniki, Greece
Bobeck S. Modjtahedi, Southern California Permanente Medical Group, California, USA
Eleni Nikita, Manchester Royal Eye Hospital, Manchester, UK
Praveen Patel, Moorfields Eye Hospital, London, UK
Giuseppe Querques, University Vita Salute, Milan, Italy
Srinivas R. Sadda, University of Southern California, Los Angeles, CA, USA
Jose-Alain Sahel, Institut de la Vision, Paris, France
Srilakshmi M Sharma, Johns Hopkins University, Baltimore, USA
David Steel, Sunderland Eye Infirmary, UK
Michael W. Stewart, Mayo School of Medicine, Jacksonville, USA
Clive Wilson, Strathclyde University, Glasgow, UK

Advisory Board

The advisory board are primarily responsible for providing peer review comments which helps the in-house editorial team maintain our rapid publication timelines. The advisory board also contribute their own research and reviews.

Dhanesh Amarnani, Harvard Medical School, Boston, USA
Ejaz Ansari, University of Kent at Canterbury, Canterbury, UK
Pasquale Aragona, University of Messina, Messina, Italy
Ahmed Aref, UIC Eye & Ear Infirmary, Chicago, USA
Francesco Bandello, University of Udine, Udine, Italy
Noel Bauer, University Eye Clinic Maastricht, Maastricht, The Netherlands
Kostas Boboridis, Aristotle University of Thessaloniki, Thessaloniki, Greece
David Boyer, Retina-Vitreous Associates Medical Group, Beverly Hills, USA
Adriano Carnevali, University "Magna Graecia" of Catanzaro; University Vita-Salute, IRCSS Ospedale San Raffaele, Italy
Irini Chatziralli, University of Athens, Athens, Greece
Zia Chaudhuri, Lady Hardinge Medical College, New Delhi, India
Jiaqi Chen, Sun Yat-sen University, Guangdong, China
Maria Vittoria Cicinelli, San Raffaele Scientific Institute, Italy
Jessica Ciralsky, Weill Cornell Medical College, New York, USA
Anna Dastiridou, University of Thessaly, Larissa, Greece
Syril Dorairaj, Mayo Clinic College of Medicine and Science, Jacksonville, USA
Theodoros Empeslidis, Spire Leicester Hospital, Leicester, UK
Stefano Gandolfi, Università di Parma, Parma, Italy
Shane Havens, University of Nebraska Medical Center, Omaha, USA
Martina Herwig, University of Bonn, Bonn, Germany
Jean Pierre Hubschman, University of California, Los Angeles, USA
Alexander Ionides, Moorfields, London, UK 
Mahmoud M. Ismail, Al-Azhar University, Egypt
Mitchell Jackson, Jackson Eye, Lake Villa, USA
Soosan Jacob, Dr. Agarwal's Group of Eye Hospitals, Chennai, India
Ingrida Januleviciene, Lithuanian University of Health Sciences, Lithuanian
Andreas Katsanos, University of Ioannina, Ioannina, Greece
Motoko Kawashima, Keio University, Tokyo, Japan
M. Selim Kocabora, Istanbul Medipol University, Turkey
Takeya Kohno, Osaka City University, Japan
George Kymionis, Vardinoyiannion Eye Institute of Crete, Crete 
Scott Lawrence, University of North Carolina, Chapel Hill, USA 
Jacky Wai Yip Lee, The University of Hong Kong, Hong Kong, China
Norah Lincoff, Buffalo General Medical Center, Buffalo, USA
Nikolas London, Moorfields, London, UK
Jodi Luchs, Hofstra University School of Medicine, New York, USA
Habib Maged, Sunderland Eye Infirmary, Sunderland, UK
Sajjad Mahmood, Manchester Royal Eye Hospital, Manchester, UK
Alberto Lopez Miguel, IOBA Universidad de Valladolid, Spain
Darlene Miller, University of Miami Miller School of Medicine, Miami, USA
Tatsuya Mimura, University of Tokyo Graduate School of Medicine, Tokyo, Japan
Majid Moshirfar, Old Mill Medical Center, Utah, USA
Dhananjay Pal, UMKC School of Pharmacy, Kansas City, USA
Cintia De Paiva, Cullen Eye Institute, Baylor College of Medicine, Houston, USA
Luciano Quaranta, University of Brescia, Brescia, Italy
Jullia A Rosdahl, Duke University, Durham, USA
Maria Teresa Sandinha, Sunderland Eye Infirmary, Sunderland, UK
Richard Scawn, Bupa Cromwell Hospital, London, UK
Karen Schaal, Universitätsspital Bern, Bern, Switzerland
Silvana Schellini, São Paulo State University, São Paulo, Brazil
Robert Sergott, Thomas Jefferson University Medical College, Philadelphia, USA
Brent Alan Siesky, Indiana University School of Medicine, Indianapolis, USA
Rufino Silva, University Hospital of Coimbra, Coimbra, Portugal
Ajay Singh, University of Kansas Ophthalmology, Kansas, USA
Sobha Sivaprasad, King's College Hospital, London, UK
Jeffrey Soohoo, University of Colorado, USA
Divya Srikumaran, Johns Hopkins University School of  Medicine, Baltimore, USA
Yousif Subhi, Zealand Univ. Hospital, Roskilde, Denmark
Amparo Navea Tejerina, CEU Cardenal Herrera University, Alfara del Patriarca, Spain
Asheesh Tewari, Wayne State University, Detroit, USA
Louis Tong, National University of Singapore, Singapore
Koushik Tripathy, ICARE Eye Hospital & Postgraduate Institute, Noida, India
Nitin Verma, The Royal Hobart Hospital, Hobart, Australia
Stela Vujosevic, IRCCS (Istituto Ricerca e Cura a Carattere Scientifico), Rome, Italy
Hua-Tao Xie, Harvard Medical School, Boston, USA
Kunyong Xu, Queen's University, Ontario, Canada
Pei Xu, University of Texas Medical Branch, USA
Zhaotian Zhang, Sun Yat-sen University, China

For authors and editors

  • Aims and Scope

    Aims and Scope


    Aims and Scope

    Ophthalmology and Therapy is an international, open access, peer-reviewed (single-blind), and rapid publication journal. The scope of the journal is broad and will consider all scientifically sound research from preclinical, clinical (all phases), observational, real-world, and health outcomes research around the use of ophthalmological therapies, devices, and surgical techniques.

    The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research, reviews, case reports/series, trial protocols and short communications such as commentaries and editorials. Ophthalmology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of quality research, which may be considered of insufficient interest by other journals.

    Rapid Publication

    The journal’s publication timelines aim for a rapid peer review of 2 weeks. If an article is accepted it will be published 3–4 weeks from acceptance. The rapid timelines are achieved through the combination of a dedicated in-house editorial team, who manage article workflow, and an extensive Editorial and Advisory Board who assist with peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid, efficient communication of the latest research and reviews, fostering the advancement of ophthalmic therapies.

    Personal Service

    The journal’s dedicated in-house editorial team offer a personal “concierge service” meaning authors will always have an editorial contact able to update them on the status of their manuscript.  The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research.

    Enhanced Digital Features

    Ophthalmology and Therapy
    offers a range of additional enhanced digital features designed to increase visibility, readership, and the educational value of the content. Each paper is accompanied by a bulleted summary slide, giving a time-efficient overview of the content to a wide readership. Articles also have the option to include other enhanced digital features including (but not limited to) slide sets, videos, video abstracts, podcasts, infographics and animations. All these enhanced digital features are open access and are peer reviewed to the same high standard as the article itself. By having a choice of media not limited to text, figures and tables alone, readers may receive information more effectively, whilst being reassured that the content has undergone the same rigorous peer review as the original article. Offering succinct multimedia formats can support time-pressed healthcare professionals in keeping on top of recently published research. For questions relating specifically to these features, please contact adisdigitalfeatures@springer.com.
    Plain Language Summaries

    Articles published in Ophthalmology and Therapy may be accompanied by plain language summaries to assist non-experts (including non-specialists, patients, caregivers and others) in understanding important medical advances. Both the enhanced digital features and plain language summaries can help to reach a broader audience thus supporting the effective dissemination of research.

    Publication Fees

    Upon acceptance of an article, authors will be required to pay the article processing charge and open access fee of €340/ $380 per typeset page. The journal will consider fee discounts and waivers for developing countries and this is decided on a case by case basis. Considering the time and effort required for a detailed peer review we also reward our regular reviewers with the opportunity to publish without article processing charges (pending peer review) for every three reviews completed per calendar year. 

    Peer Review Process

    Upon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.

    At least two extensive reviews are required to make the editorial decision. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision. Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.


    Ophthalmology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0.


    For more information about the journal, including pre-submission enquiries, please contact christopher.vautrinot@springer.com.

  • Submit Online
  • Instructions for Authors (pdf, 474 kB)
  • Compliance with Ethical Policies
  • Author Disclosure Form (docx, 45 kB)
  • Author Academy: Training for Authors
  • Copyright Information

    Copyright Information


    Copyright Information

    Open Access Ophthalmology and Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0

    Journal ownership: Springer Healthcare

    Copyright of articles: © The Author(s)

Alerts for this journal


Get the table of contents of every new issue published in Ophthalmology and Therapy.

Additional information